Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Left-right determination factor 3 pseudogene (LEFTY3P) is a genomic DNA locus sharing sequence similarity with left-right determination factor (LEFTY) proteins, which are involved in embryonic pattern formation. LEFTY3P is classified as a pseudogene—meaning it lacks a functional coding capacity, typically due to disabling mutations, deletions, or absence of regulatory control elements. While some pseudogenes may exert subtle regulatory effects at the RNA level, the majority are considered nonfunctional molecular fossils. There is no published evidence that LEFTY3P is actively transcribed, translated, or involved in human disease. Therefore, LEFTY3P is not considered a therapeutic target or subject to drug interactions, and may be a misclassified or redundant database entry rather than a bona fide molecular entity[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Left-right determination factor 3 pseudogene (LEFTY3P).